Detalles de la búsqueda
1.
The prognostic role of soluble transforming growth factor-ß and its correlation with soluble programmed death-ligand 1 in biliary tract cancer.
Liver Int
; 41(2): 388-395, 2021 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-32780918
2.
WEE1 inhibition reverses trastuzumab resistance in HER2-positive cancers.
Gastric Cancer
; 24(5): 1003-1020, 2021 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-33723720
3.
Enhanced antitumor effect of binimetinib in combination with capecitabine for biliary tract cancer patients with mutations in the RAS/RAF/MEK/ERK pathway: phase Ib study.
Br J Cancer
; 121(4): 332-339, 2019 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-31312030
4.
GC1118, a novel anti-EGFR antibody, has potent KRAS mutation-independent antitumor activity compared with cetuximab in gastric cancer.
Gastric Cancer
; 22(5): 932-940, 2019 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-30815759
5.
Prognostic implication of antitumor immunity measured by the neutrophil-lymphocyte ratio and serum cytokines and angiogenic factors in gastric cancer.
Gastric Cancer
; 20(2): 254-262, 2017 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-27147244
6.
Signature of cytokines and angiogenic factors (CAFs) defines a clinically distinct subgroup of gastric cancer.
Gastric Cancer
; 20(1): 164-174, 2017 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-26681196
7.
The effect of abdominal drawing-in exercise and myofascial release on pain, flexibility, and balance of elderly females.
J Phys Ther Sci
; 28(10): 2812-2815, 2016 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-27821941
8.
BCR-ABL1 doubling times more reliably assess the dynamics of CML relapse compared with the BCR-ABL1 fold rise: implications for monitoring and management.
Blood
; 119(18): 4264-71, 2012 May 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-22431575
9.
Predictive factors for successful imatinib cessation in chronic myeloid leukemia patients treated with imatinib.
Am J Hematol
; 88(6): 449-54, 2013 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-23440689
10.
A synthetic lethal strategy using PARP and ATM inhibition for overcoming trastuzumab resistance in HER2-positive cancers.
Oncogene
; 41(32): 3939-3952, 2022 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-35798878
11.
Inhibition of WEE1 Potentiates Sensitivity to PARP Inhibitor in Biliary Tract Cancer.
Cancer Res Treat
; 54(2): 541-553, 2022 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-34352995
12.
Gemcitabine and cisplatin plus durvalumab with or without tremelimumab in chemotherapy-naive patients with advanced biliary tract cancer: an open-label, single-centre, phase 2 study.
Lancet Gastroenterol Hepatol
; 7(6): 522-532, 2022 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-35278356
13.
ATR inhibition amplifies antitumor effects of olaparib in biliary tract cancer.
Cancer Lett
; 516: 38-47, 2021 09 28.
Artículo
en Inglés
| MEDLINE | ID: mdl-34082024
14.
Prognostic Value of Serum Soluble Programmed Death-Ligand 1 and Dynamics During Chemotherapy in Advanced Gastric Cancer Patients.
Cancer Res Treat
; 53(1): 199-206, 2021 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-33070562
15.
Inhibition of ATR Increases the Sensitivity to WEE1 Inhibitor in Biliary Tract Cancer.
Cancer Res Treat
; 52(3): 945-956, 2020 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-32311864
16.
Therapeutic Co-targeting of WEE1 and ATM Downregulates PD-L1 Expression in Pancreatic Cancer.
Cancer Res Treat
; 52(1): 149-166, 2020 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-31291716
17.
The prognostic role of soluble TGF-beta and its dynamics in unresectable pancreatic cancer treated with chemotherapy.
Cancer Med
; 9(1): 43-51, 2020 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-31701645
18.
Prognostic implications of soluble programmed death-ligand 1 and its dynamics during chemotherapy in unresectable pancreatic cancer.
Sci Rep
; 9(1): 11131, 2019 07 31.
Artículo
en Inglés
| MEDLINE | ID: mdl-31366979
19.
Dynamics of Soluble Programmed Death-Ligand 1 (sPDL1) during Chemotherapy and Its Prognostic Implications in Cancer Patients: Biomarker Development in Immuno-oncology.
Cancer Res Treat
; 51(2): 832-840, 2019 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-30309223
20.
Therapeutic Targeting of the DNA Damage Response Using an ATR Inhibitor in Biliary Tract Cancer.
Cancer Res Treat
; 51(3): 1167-1179, 2019 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-30514066